BCM
SEM

Bluefin Capital Management’s Select Medical SEM Stock Holding History

Bluefin Capital Management’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.3M Buy
+200,000
New +$3.3M 0.83% 21

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Bluefin Capital Management's SEM Position: Q2 2026 in Review

Bluefin Capital Management opened a new position in Select Medical (SEM) in Q2 2026: 200,000 shares worth $3.3M. The stake represents 0.83% of the portfolio and ranks #21 among its holdings.

239 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Bluefin Capital Management held 200,000 shares of Select Medical worth $3.3M as of Q2 2026.
  • Select Medical was a new Bluefin Capital Management position in Q2 2026.
  • Select Medical made up 0.83% of Bluefin Capital Management's portfolio in Q2 2026, its #21 holding.
  • 239 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Bluefin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.